Clinical Trials

    Showing 1 - 1 of 1 Heart Transplant

    CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

    Status: Open Not Enrolling

    Investigator: Mahwash Kassi

    Study Coordinator: Jan-Michael Ragunton

    Phone: 346.238.0218

    To evaluate the efficacy of eplontersen compared to placebo for 120 weeks in patients with ATTR-CM receiving available standard of care (SoC). For more information, please visit https://www.cardio-ttransform.com.... Read more >